Research has shown that increased activity of eEF2K is found in the hippocampus of deceased patients with Alzheimer’s disease, and inhibiting the activity of eEF2K can prevent the toxic effects of Aβ42 oligomers on neurons [40]. Here, EEF2K is linked to early-onset autosomal dominant Alzheimer disease.